Table of content for "Tocilizumab for covid-19" (HCPCS Q0249)
General information on the “Q0249” code
HCPCS Code: Q0249
Long Description: Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg
Short Description: Tocilizumab for covid-19
Original information is taken from Q0249 page
Pricing indicators
Pricing Indicator Code 1: 54 – Vaccinations
Multiple Pricing Indicator Code A : Not applicable as HCPCS priced under one methodology
Certification and additional reference information
Coverage
Coverage: C – Carrier judgment
Type of service
Berenson-Eggers Type of Service (BETOS): O1G – Immunizations/Vaccinations
Type Of Service 1: V – Pneumococcal/flu vaccine (eff 01/96), Pneumococcal/flu/hepatitis B vaccine (eff 04/95-12/95), Pneumococcal only before 04/95
Misc information
Anesthesia Base Unit Quantity: 0
Code Added Date: 20210624
Code Effective Date: 20210624
Action Code: N – No maintenance for this code